BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12711645)

  • 21. Evaluation of the introduction of a 'traffic light protocol' for dose-volume histogram constraints of organs at risk in definitive radiotherapy at Liverpool and Macarthur Cancer Therapy Centres.
    Kasraei F; Ochoa C; Vial P; Lee MT
    J Med Imaging Radiat Oncol; 2020 Jun; 64(3):427-434. PubMed ID: 32237046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
    Diez P; Hoskin PJ; Aird EG
    Br J Radiol; 2007 Oct; 80(958):816-21. PubMed ID: 17959922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automation and intensity modulated radiation therapy for individualized high-quality tangent breast treatment plans.
    Purdie TG; Dinniwell RE; Fyles A; Sharpe MB
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):688-95. PubMed ID: 25160607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional dose distribution of tangential breast treatment: a national dosimetry intercomparison.
    van Bree NA; van Battum LJ; Huizenga H; Mijnheer BJ
    Radiother Oncol; 1991 Dec; 22(4):252-60. PubMed ID: 1792317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single isocenter technique using CT-based planning in the treatment of breast cancer.
    Edlund T; Gannett D
    Med Dosim; 1999; 24(4):239-45. PubMed ID: 10643732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.
    Mason MD; Moore R; Jones G; Lewis G; Donovan JL; Neal DE; Hamdy FC; Lane JA; Staffurth JN;
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e92-e100. PubMed ID: 27425582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Approaches to individual radiotherapy in breast cancer: individual risk estimation and individualized techniques].
    Kahán Z; Varga Z; Csenki M; Szabó J; Szil E; Fekete G; Hideghéty K; Boda K; Thurzó L
    Orv Hetil; 2007 May; 148(18):833-41. PubMed ID: 17468066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMRT for the breast: a comparison of tangential planning techniques.
    Smith W; Menon G; Wolfe N; Ploquin N; Trotter T; Pudney D
    Phys Med Biol; 2010 Feb; 55(4):1231-41. PubMed ID: 20124651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commissioning and quality assurance of the Pinnacle(3) radiotherapy treatment planning system for external beam photons.
    Bedford JL; Childs PJ; Nordmark Hansen V; Mosleh-Shirazi MA; Verhaegen F; Warrington AP
    Br J Radiol; 2003 Mar; 76(903):163-76. PubMed ID: 12684232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irradiation of the heart during tangential breast treatment: a study within the START trial.
    Venables K; Miles EA; Deighton A; Aird EG; Hoskin PJ
    Br J Radiol; 2004 Feb; 77(914):137-42. PubMed ID: 15010386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation.
    Venables K; Winfield EA; Aird EG; Hoskin PJ
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):271-9. PubMed ID: 12504061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centre credentialing for Trans Tasman Radiation Oncology Group trial 06.02: multicentre feasibility study of accelerated partial breast irradiation.
    Kron T; Willis D; Bignell F; Martland J; Donnell S; May S; Chua BH
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):412-8. PubMed ID: 19695049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need for individualized dosimetry for tangential breast treatment.
    Dunlap B; Olch A; Wollin M; Kagan AR
    Med Dosim; 1997; 22(4):315-8. PubMed ID: 9503375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance.
    Das RK; Patel R; Shah H; Odau H; Kuske RR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1224-8. PubMed ID: 15234059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric and treatment planning considerations for radiotherapy of the chest wall.
    Aspradakis MM; McCallum HM; Wilson N
    Br J Radiol; 2006 Oct; 79(946):828-36. PubMed ID: 16687464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
    Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
    Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
    Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
    Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
    Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.